SPEG and centronuclear myopathy: Although it is still unclear if SPEG is also a negative regulator of dynamin 2, gene silencing of DNM2 may be a potential therapeutic approach for CNM caused by variants in DNM2 gene as well as for CNM associated with variants in other genes such as MTM1, BIN1, SPEG.